VivoSim Labs Statistics
NASDAQ: VIVSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.1807+0.0035 (+1.97%)
Market open · Delayed 15 min · as of Oct 9, 2:15 PM ET
VivoSim Labs by the numbers
VivoSim Labs has a market capitalization of $3.0 million based on 16.59M shares outstanding. With trailing EPS of $-4.47, VivoSim Labs is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 35.6% below its 50-day average and 85.2% below its 200-day average.
Average daily trading volume is 5.85M shares, or about $1.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VIVS valuation vs. peer median
| Metric | VIVS | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.00M | $3.48M | -14% |
| Avg. volume | 5.85M | 546.77K | +971% |
Peer median across 8 companies: SLXN, HLSQ, CLDI, CRIS, SCNI, PMCB, LIMN, CELZ.
Valuation
- Market cap
- $3.00M
- EPS (TTM)
- $-4.47
- Shares outstanding
- 16.59M
Price and trading
- Previous close
- 0.1772
- Open
- 0.1776
- Day range
- 0.1681 – 0.1836
- 52-week range
- 0.1681 – 3.41
- 50-day moving average
- 0.2804
- Beta
- —
- Volume
- 292.91K
- Average volume
- 5.85M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 3.00M
- Eps
- -4.47
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.41
- Week52 Low
- 0.17
- Avg Volume
- 5.85M
- Shares Outstanding
- 16.59M
- Ma50
- 0.28
- Ma200
- 1.22
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -94.70%
- Pct From52w Low
- 7.50%